| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/21/2008 | US20080045579 Oxazolidine derivatives as PR modulators |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045535 Prokineticin 2 receptor antagonists |
| 02/21/2008 | US20080045531 Anti-inflammatory medicaments |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045466 Progression Inhibitor For Disease Attributed To Abnormal Accumulation Of Liver Fat |
| 02/21/2008 | US20080045462 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
| 02/21/2008 | US20080045450 GLP-2 Derivatives |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044502 Use of an aqueous or hydroalcoholic extract of bauhinia for the preparation of a composition |
| 02/21/2008 | US20080044493 Agent For Ameliorating The Maximum Passage Time Through Digestive Tract, Agent For Ameliorating Passage Time Through Digestive Tract And Preventive For Colon Cancer |
| 02/21/2008 | US20080044489 Low dose colonic cleansing system |
| 02/21/2008 | US20080044477 Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044401 Drug therapy for celiac sprue |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044353 Combination Therapy for Weight Management |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/20/2008 | EP1889848A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 02/20/2008 | EP1889841A1 Crystal of salt of benzimidazole compound |
| 02/20/2008 | EP1889058A1 Diagnosis and treatment of endometriosis |
| 02/20/2008 | EP1888074A1 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
| 02/20/2008 | EP1888025A2 Medicament carrier composition and method of forming a film therefrom |
| 02/20/2008 | EP1888014A1 Dental mineralization |
| 02/20/2008 | EP1651217B1 Alkaline salts of proton pump inhibitors |
| 02/20/2008 | EP1424907B1 Oil composition |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1285947B1 Antimicrobial composition |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1127059B1 Imidazonaphthyridines |
| 02/20/2008 | EP0870500B1 Anti-helicobacter pylori agent |
| 02/20/2008 | CN101128487A Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128129A Nutritional composition with probiotics |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126057A Kudzu root health care medicinal liquor |
| 02/20/2008 | CN101125855A Method for separating hemporfin isomer and separated isomer |
| 02/20/2008 | CN101125202A Protein vaccine used for processing immune tolerant treatment to hepatitis B |
| 02/20/2008 | CN101125197A Oral preparation for regulating spleen-stomach deficiency-cold type diarrhea and its preparation method |
| 02/20/2008 | CN101125195A Orally administered traditional Chinese medicine for treating chronic atrophic gastritis |
| 02/20/2008 | CN101125194A Medicine composition for curing infantile diarrhea |
| 02/20/2008 | CN101125192A Granule preparation for preventing and treating viral hepatitis associated with liver blood stasis |
| 02/20/2008 | CN101125188A Medicine for restoring gastric mucosa |
| 02/20/2008 | CN101125185A Traditional Chinese medicine for treating fatty liver |
| 02/20/2008 | CN101125183A Spleen-invigorating stomach-protecting granule medicine |
| 02/20/2008 | CN101125171A Reinforced traditional Chinese medicine for male and female |
| 02/20/2008 | CN101125169A Health-care wine |
| 02/20/2008 | CN101125168A New use of wrinkled glanthyssop vital energy preparation |
| 02/20/2008 | CN101125160A Method for preparing preparation for treating gastroenteritis and its new use |
| 02/20/2008 | CN101125158A Traditional Chinese medicine patch for treating infantile diarrhea and preparation method thereof |
| 02/20/2008 | CN101125153A Acanthopanax root granule and its preparation method |
| 02/20/2008 | CN101125148A Method for preparing montmorillonite gel preparation |
| 02/20/2008 | CN101125141A Anticancer medicine composition and its application in preparing anticancer medicine |
| 02/20/2008 | CN101124993A Production method of health-care food for lithiasis patient |
| 02/20/2008 | CN101124992A 'Jinsuoyinkai' health-care sugar and production technology thereof |
| 02/20/2008 | CN101124978A Litsea lam season oil and preparation method thereof and application of letsea lam volatile oil in season oil |
| 02/20/2008 | CN101124932A Decoction preparation for treating viral hepatitis associated with fatty liver diseases |
| 02/20/2008 | CN100369925C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369616C Glossy ganoderma essence liquid |
| 02/20/2008 | CN100369614C Quality control method of compound gallblader freeflow solid preparation |
| 02/20/2008 | CN100369603C Product recipe for bee glue soft capsule inclusion |
| 02/20/2008 | CN100369558C Edible oil palm fibre powder ,food containing the same and production method |
| 02/19/2008 | US7332522 Liver function protecting or ameliorating agent |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332336 Methods for inducing differentiation of pluripotent cells |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332184 Colonic cleansing composition and method |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2413844C The effect of a buffering agent on acidogenesis of plaque |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2286756C Use of zinc hyaluronate against peptic ulcer |
| 02/19/2008 | CA2277207C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008018825A1 Oral polyvinyl alcohol capsules comprising proton pump inhibitors |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008017845A1 Apples with high polyphenolic content |
| 02/14/2008 | WO2008017842A1 Polyphenol extraction process |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017752A2 Eucalyptus extract, method of preparation and therapeutic uses thereof |